Suzuki, Tomotaka
Kusumoto, Shigeru http://orcid.org/0000-0001-6546-1279
Kamezaki, Yoshiko
Hashimoto, Hiroya
Nishitarumizu, Nozomi
Nakanishi, Yoko
Kato, Yukiyasu
Kawai, Akimi
Matsunaga, Naohiro
Ebina, Toru
Nakamura, Tomoyuki
Marumo, Yoshiaki
Oiwa, Kana
Kinoshita, Shiori
Narita, Tomoko
Ito, Asahi
Inagaki, Atsushi
Ri, Masaki
Komatsu, Hirokazu
Aritsu, Takashi
Iida, Shinsuke
Funding for this research was provided by:
National Cancer Center Research and Development Fund (2020-J-3)
Article History
Received: 13 November 2022
Revised: 23 January 2023
Accepted: 24 January 2023
First Online: 15 February 2023
Declarations
:
: Dr. Iida reports research funding and consulting fees from Pfizer. All other authors declare that they have no conflict of interest.
: This study was approved by the Institutional Review Board of the Nagoya City University Hospital and was conducted in accordance with the principles of the Declaration of Helsinki.
: Written informed consent was obtained from all participants to store their blood samples.
Free to read: This content has been made available to all.